or Try an Advanced Search...

    Technical Analysis for BTAI - BioXcel Therapeutics, Inc.

    Grade Last Price % Change Price Change
    F 1.17 -8.59% -0.11
    BTAI closed down 8.59 percent on Monday, July 1, 2024, on approximately normal volume.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical BTAI trend table...
    Date Alert Name Type % Chg
    New Downtrend Bearish 0.00%
    Wide Bands Range Expansion 0.00%
    20 DMA Resistance Bearish -8.59%
    New Uptrend Bullish -8.59%
    Pocket Pivot Bullish Swing Setup -8.59%
    Volume Surge Other -8.59%
    Calm After Storm Range Contraction -8.59%
    Wide Bands Range Expansion -8.59%
    Calm After Storm Range Contraction -7.87%
    Wide Bands Range Expansion -7.87%
    Older End-of-Day Signals for BTAI ...

       Recent Intraday Alerts

    Alert Time
    Down 10% about 7 hours ago
    1.5x Volume Pace about 9 hours ago
    Down 5% about 9 hours ago
    60 Minute Opening Range Breakdown about 9 hours ago
    Fell Below 10 DMA about 9 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    BTAI Chart by TradingView
    Basic chart:

    Profile

    BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company which is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Artificial Intelligence Neuroscience Drug Development Cybernetics Computational Neuroscience

    Is BTAI a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 25 BioXcel Therapeutics' Approved Drug For Bipolar Disorders/Schizophrenia Shows No Evidence Of Worsening Or Withdrawal In Post-Marketing Study
    Jun 25 BioXcel Therapeutics Announces Positive Topline Results from Post-Marketing Requirement Study Evaluating PRN Treatment of IGALMI™ (dexmedetomidine) Sublingual Film for Agitation Associated with Bipolar Disorders or Schizophrenia
    May 28 BioXcel Therapeutics to Present at Jefferies Global Healthcare Conference
    May 21 BioXcel Therapeutics Announces Oral and Poster Presentations at the 2024 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting
    May 10 BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Q1 2024 Earnings Call Transcript
    May 10 BioXcel Therapeutics First Quarter 2024 Earnings: Misses Expectations
    May 10 Q1 2024 BioXcel Therapeutics Inc Earnings Call
    May 9 BioXcel Therapeutics, Inc. (BTAI) Q1 2024 Earnings Call Transcript
    May 9 BioXcel Therapeutics GAAP EPS of -$0.87 misses by $0.12, revenue of $0.58M misses by $0.05M
    May 9 BioXcel Therapeutics Reports First Quarter 2024 Financial Results
    See more BTAI news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 12.3999
    52 Week Low 1.11
    Average Volume 636,616
    200-Day Moving Average 2.85
    50-Day Moving Average 1.91
    20-Day Moving Average 1.36
    10-Day Moving Average 1.22
    Average True Range 0.14
    RSI (14) 29.08
    ADX 34.46
    +DI 23.94
    -DI 27.47
    Chandelier Exit (Long, 3 ATRs) 1.50
    Chandelier Exit (Short, 3 ATRs) 1.54
    Upper Bollinger Bands 1.68
    Lower Bollinger Band 1.04
    Percent B (%b) 0.21
    BandWidth 47.74
    MACD Line -0.20
    MACD Signal Line -0.22
    MACD Histogram 0.0248
    Fundamentals Value
    Market Cap 35.55 Million
    Num Shares 30.4 Million
    EPS -7.36
    Price-to-Earnings (P/E) Ratio -0.16
    Price-to-Sales 92.61
    Price-to-Book 3.97
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.43
    Resistance 3 (R3) 1.45 1.38 1.38
    Resistance 2 (R2) 1.38 1.32 1.37 1.37
    Resistance 1 (R1) 1.28 1.28 1.25 1.26 1.35
    Pivot Point 1.21 1.21 1.20 1.20 1.21
    Support 1 (S1) 1.11 1.15 1.08 1.09 0.99
    Support 2 (S2) 1.04 1.11 1.03 0.97
    Support 3 (S3) 0.94 1.04 0.96
    Support 4 (S4) 0.92